Litcius/Paper detail

INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer—Toxicity Update on First 213 Patients

Prarabdh Singh, J.A. Efstathiou, M. Plets, Samyukta Jhavar, S. Delacroix, A. Tripathi, A. Gupta, S. Sachdev, A. Jani, A.N. Kirschner, C. Tangen, Rick Bangs, M. Joshi, B.A. Costello, I.L. Thompson, F.Y. Feng, S. Lerner

2022International Journal of Radiation Oncology*Biology*Physics10 citationsDOI

Topics & Concepts

MedicineAtezolizumabUrologyBladder cancerRegimenRadiation therapyGemcitabineOncologyInternal medicineRandomized controlled trialChemotherapyChemoradiotherapyCancerImmunotherapyPembrolizumabBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesCancer Diagnosis and Treatment